Trinity Biotech (TRIB) Share-based Compensation (IS) (2021 - 2024)
Historic Share-based Compensation (IS) for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to $140000.0.
- Trinity Biotech's Share-based Compensation (IS) rose 11387.51% to $140000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$130750.0, marking a year-over-year decrease of 11121.36%. This contributed to the annual value of $1.3 million for FY2024, which is 3639.44% down from last year.
- Trinity Biotech's Share-based Compensation (IS) amounted to $140000.0 in Q4 2024, which was up 11387.51% from $250.0 recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's Share-based Compensation (IS) ranged from a high of $1.3 million in Q4 2022 and a low of -$1.0 million during Q4 2023
- In the last 4 years, Trinity Biotech's Share-based Compensation (IS) had a median value of $119000.0 in 2022 and averaged $162298.2.
- In the last 5 years, Trinity Biotech's Share-based Compensation (IS) surged by 75584.42% in 2022 and then crashed by 17655.54% in 2023.
- Trinity Biotech's Share-based Compensation (IS) (Quarter) stood at $154000.0 in 2021, then surged by 755.84% to $1.3 million in 2022, then plummeted by 176.56% to -$1.0 million in 2023, then soared by 113.88% to $140000.0 in 2024.
- Its last three reported values are $140000.0 in Q4 2024, $250.0 for Q3 2024, and -$1.0 million during Q4 2023.